Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The microtubule- and PP1-binding activities of Drosophila melanogaster Spc105 control the kinetics of SAC satisfaction. | Mol Biol Cell | 2022 | 34705493 | PubTator, text mining | PubMed |
| Cancer predisposition genes in Japanese children with rhabdomyosarcoma. | J Hum Genet | 2022 | 34257391 | PubTator, text mining | PubMed |
| KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker. | Comb Chem High Throughput Screen | 2022 | 34238152 | PubTator, text mining | PubMed |
| Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy. | Mol Oncol | 2022 | 34050611 | PubTator, text mining | PubMed |
| Identification of key regulators associated with colon cancer prognosis and pathogenesis. | J Cell Commun Signal | 2022 | 33770351 | PubTator, text mining | PubMed |
| Multi-omics tumor profiling technologies to develop precision medicine in multiple myeloma. | Explor Target Antitumor Ther | 2021 | 36046090 | PubTator, text mining | PubMed |
| Anticancer potential of nitric oxide (NO) in neuroblastoma treatment. | RSC Adv | 2021 | 35423416 | PubTator, text mining | PubMed |
| Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer. | Front Oncol | 2021 | 35155196 | PubTator, text mining | PubMed |
| Systematically integrative analysis identifies diagnostic and prognostic candidates and small-molecule drugs for lung adenocarcinoma. | Transl Cancer Res | 2021 | 35116665 | PubTator, text mining | PubMed |
| Identification of hub genes in key hallmarks of ovarian cancer via bioinformatics analysis. | Transl Cancer Res | 2021 | 35116413 | PubTator, text mining | PubMed |
| Identification of CDK1 as a candidate marker in cutaneous squamous cell carcinoma by integrated bioinformatics analysis. | Transl Cancer Res | 2021 | 35116276 | PubTator, text mining | PubMed |
| Overexpression of SKA Complex Is Associated With Poor Prognosis in Gliomas. | Front Neurol | 2021 | 35095717 | PubTator, text mining | PubMed |
| Development of the Japanese Version of the State Self-Compassion Scale (SSCS-J). | Front Psychol | 2021 | 35095662 | PubTator, text mining | PubMed |
| Transcriptomic and Lipidomic Profiles in Nasal Polyps of Glucocorticoid Responders and Non-Responders: Before and After Treatment. | Front Pharmacol | 2021 | 35095530 | PubTator, text mining | PubMed |
| miR-210 Regulates Apoptotic Cell Death during Cellular Hypoxia and Reoxygenation in a Diametrically Opposite Manner. | Biomedicines | 2021 | 35052722 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma. | Front Oncol | 2021 | 34993155 | PubTator, text mining | PubMed |
| Overexpression of SKA3 correlates with poor prognosis in female early breast cancer. | PeerJ | 2021 | 34993016 | PubTator, text mining | PubMed |
| A Novel Glycosyltransferase-Related Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer. | Int J Gen Med | 2021 | 34992448 | PubTator, text mining | PubMed |
| HMGB3 is Associated With an Unfavorable Prognosis of Neuroblastoma and Promotes Tumor Progression by Mediating TPX2. | Front Cell Dev Biol | 2021 | 34988076 | PubTator, text mining | PubMed |
| Weighted Gene Correlation Network Analysis Identifies Specific Functional Modules and Genes in Esophageal Cancer. | J Oncol | 2021 | 34987580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=46